{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-001679","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.985714+00:00","generated_at":"2026-05-26T01:43:59.530464+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aclaris Q4 net loss $96.6M, revenue $9.2M; cash $203.9M; pipeline catalysts in H1 2025","bullets":["Net loss $96.6M in Q4 2024 vs $1.5M in Q4 2023; included $86.9M in-process R&D charge from bosakitug license.","Revenue $9.2M in Q4 2024 vs $17.6M in Q4 2023; full year revenue $18.7M vs $31.2M.","Cash, equivalents and marketable securities $203.9M at Dec 31, 2024; cash runway expected into 2028.","Phase 2 data from partner CTTQ in severe asthma and CRSwNP expected H1 2025; Phase 2b for bosakitug in AD enrollment H1 2025.","Leadership changes: Neal Walker named CEO; Hugh Davis appointed President and COO."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-001679","json":"https://secwatch.observer/filing/0001558370-25-001679.json","markdown":"https://secwatch.observer/filing/0001558370-25-001679.md","text":"https://secwatch.observer/filing/0001558370-25-001679.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000155837025001679/0001558370-25-001679-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000155837025001679/acrs-20250227x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:43:59.530464+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}